{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:09Z","timestamp":1761129489726},"reference-count":49,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.8867-17","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:12:48Z","timestamp":1507673568000},"page":"487-495","source":"Crossref","is-referenced-by-count":8,"title":["Isolation of ESBL-producing Bacteria from Sputum in Community-acquired Pneumonia or Healthcare-associated Pneumonia Does Not Indicate the Need for Antibiotics with Activity against This Class"],"prefix":"10.2169","volume":"57","author":[{"given":"Hideyuki","family":"Horie","sequence":"first","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Ito","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"},{"name":"Department of Respiratory Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Konishi","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"},{"name":"Department of Respiratory Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"},{"name":"Department of Respiratory Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"},{"name":"Department of Respiratory Medicine, Kyoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Uchida","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bush K, Jacoby GA. Update functional classification of \u03b2-lactamases. Antimicrob Agents Chemother 54: 969-976, 2010.","DOI":"10.1128\/AAC.01009-09"},{"key":"2","unstructured":"2. Wayne PA. Performance standards for antimicrobial susceptibility testing. 2012. CLSI Document M100-S22. Clinical and Laboratory Standards Institute."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sader HS, Flamm RK, Jones RN. Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011). Diagn Microbiol Infect Dis 76: 217-221, 2013.","DOI":"10.1016\/j.diagmicrobio.2013.02.009"},{"key":"4","unstructured":"4. Yamaguchi K, Saikawa T, Yanagihara K, et al. <i>In vitro<\/i> susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007. Jpn J Antibiot 62: 346-370, 2009."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hirakata Y, Inoue M, Turnidge JD, et al. Regional variation in the prevalence of extended-spectrum \u03b2-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 52: 323-329, 2005.","DOI":"10.1016\/j.diagmicrobio.2005.04.004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mandell LA, File TM Jr, Musher DM, et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44: S27-S72, 2007.","DOI":"10.1086\/511159"},{"key":"7","unstructured":"7. Kalil AC, Roberts JA, Waterer GW, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis 63: 575-582, 2016."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens a systematic review and meta-analysis. Clin Infect Dis 58: 330-339, 2014.","DOI":"10.1093\/cid\/cit734"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416, 2005.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gross AE, Olsen KM, Rupp ME, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother 58: 5262-5268, 2014.","DOI":"10.1128\/AAC.02582-14"},{"key":"11","unstructured":"11. Valles J, Jimenez R, Seoane E, et al. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 40: 572-581, 2014."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shindo Y, Taniguchi H, Suzuki R, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 188: 985-995, 2013.","DOI":"10.1164\/rccm.201301-0079OC"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Seong GM, Lee J, Lee JH, et al. Healthcare-associated pneumonia among hospitalized patients: Is it different from community acquired pneumonia? Tuberc Respir Dis (Seoul) 76: 66-74, 2014.","DOI":"10.4046\/trd.2014.76.2.66"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med 106: 1606-1612, 2012.","DOI":"10.1016\/j.rmed.2012.08.003"},{"key":"15","unstructured":"15. Maruyama T, Takei Y, Miyashita N, et al. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis 57: 1373-1383, 2013."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Ma HM, Hui DS, Lui GC, et al. Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population. QJM 106: 823-829, 2013.","DOI":"10.1093\/qjmed\/hct152"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jung JY, Kim YS, Park BH, et al. Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis 11: 61, 2011.","DOI":"10.1186\/1471-2334-11-61"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Shindo Y, Ogawa M, Hashimoto N, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135: 633-640, 2009.","DOI":"10.1378\/chest.08-1357"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oshitani Y, Nagai H, Matsui H, Aoshima M. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan. J Infect Chemother 19: 579-587, 2013.","DOI":"10.1007\/s10156-012-0517-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cao G, Chen X, Wu S. Analysis of clinical efficacy of different initial antimicrobial treatment in healthcare associated pneumonia patients in emergency department. Chin Med J (Engl) 127: 1814-1819, 2014.","DOI":"10.3760\/cma.j.issn.0366-6999.20132885"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Park HK, Suh GY, Chung MP, et al. Clinical characteristics of health care-associated pneumonia in Korean teaching hospital. Respir Med 104: 1729-1735, 2010.","DOI":"10.1016\/j.rmed.2010.06.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shibata N, Ozawa Y, Shibayama K, et al. PCR classification of CTX-M-type \u03b2-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 50: 791-795, 2006.","DOI":"10.1128\/AAC.50.2.791-795.2006"},{"key":"23","first-page":"1","volume":"64","author":"WS Lim","year":"2009","unstructured":"23. Lim WS, Read RC, Roberts HJ, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64: 1-55, 2009.","journal-title":"Thorax","ISSN":"http:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jones BE, Sauer B, Madaras-Kelly K, et al. Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010. Clin Infect Dis 61: 1403-1410, 2015.","DOI":"10.1093\/cid\/civ629"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Attridge RT, Lawson KA, Ryan L, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 38: 878-887, 2011.","DOI":"10.1183\/09031936.00141110"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Teshome BF, Attridge RT, Koeller J, et al. Application of a methicillin-resistant <i>Staphylococcus aureus<\/i> risk score for community-onset pneumonia patients and outcomes with initial treatment. BMC Infect Dis 15: 380, 2015.","DOI":"10.1186\/s12879-015-1119-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chen LA, She DY, Liang ZX, et al. Healthcare-associated pneumonia clinical features and retrospective analysis over 10 years. Chin Med J (Engl) 128: 2707-2713, 2015.","DOI":"10.4103\/0366-6999.167294"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Webb BJ, Dangerfield BS, Pasha JS, et al. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med 106: 1606-1612, 2012.","DOI":"10.1016\/j.rmed.2012.08.003"},{"key":"29","unstructured":"29. Paterson DL, Bonomo RA. Extended-spectrum\u03b2-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686, 2005."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kumar D, Singh AK, Ali MR, Chander Y. Antimicrobial susceptibility profile of extended spectrum \u03b2-lactamase (ESBL) producing <i>Escherichia coli<\/i> from various clinical samples. Infect Dis (Auckl) 7: 1-8, 2014.","DOI":"10.4137\/IDRT.S13820"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157: 531-539, 1998.","DOI":"10.1164\/ajrccm.157.2.9705064"},{"key":"32","unstructured":"32. Gaynes R. Health-care associated bloodstream infections: a change in thinking. Ann Intern Med 137: 850-851, 2002."},{"key":"33","unstructured":"33. Choi SH, Lee SO, Jeong JY, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 52: 995-1000, 2008."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Jacoby GA, Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of <i>Klebsiella pneumoniae<\/i> and <i>Escherichia coli<\/i>. J Clin Microbiol 34: 908-911, 1996.","DOI":"10.1128\/jcm.34.4.908-911.1996"},{"key":"35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"35. Lim WS, Boersma WG, Karalus N, et al. Defining community-acquired pneumonia severity on presentation to hospital:an international derivation and validation study. Thorax 58: 377-382, 2003.","journal-title":"Thorax","ISSN":"http:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 6: 396-399, 1977.","DOI":"10.1128\/jcm.6.4.396-399.1977"},{"key":"37","unstructured":"37. The JRS guidelines for the management of community-acquired pneumonia in adults 2005."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Halm EA, Marrie TJ, Coley CM, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia. JAMA 279: 1452-1457, 1998.","DOI":"10.1001\/jama.279.18.1452"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Bruns AH, Oosterheert JJ, Hak E, Hoepelman AI. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 32: 726-732, 2008.","DOI":"10.1183\/09031936.00003608"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Gilbert DN. Clinical end points of therapy for patients with mild community-acquired pneumonia. Clin Infect Dis 47: 140-144, 2008.","DOI":"10.1086\/591395"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and \u03b2-lactamase activity in AmpC- and extended-spectrum \u03b2-lactamase (ESBL)-producing <i>Escherichia coli<\/i> and <i>Klebsiella pneumoniae<\/i> clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol 42: 269-275, 2004.","DOI":"10.1128\/JCM.42.1.269-275.2004"},{"key":"42","unstructured":"42. Paterson DL, Klugman KP, Bonomo RA, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39: 2206-2212, 2001."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum \u03b2-lactamases in a tertiary-care medical center. J Clin Microbiol 35: 2061-2067, 1997.","DOI":"10.1128\/jcm.35.8.2061-2067.1997"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLS. Curr Opin Pharmacol 7: 459-469, 2007.","DOI":"10.1016\/j.coph.2007.08.003"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Yang K, Guglielmo BJ. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother 41: 1427-1435, 2007.","DOI":"10.1345\/aph.1K213"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Dobler CC, Waterer G. Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too? Respirology 18: 923-932, 2013.","DOI":"10.1111\/resp.12132"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Tebano G, Augustin P, Thabut G, et al. Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation. Transpl Infect Dis 18: 22-30, 2016.","DOI":"10.1111\/tid.12471"},{"key":"48","unstructured":"48. Huang X, Li G, Yi L, Li M, Wang J. The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27: 667-671, 2015."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Ito I, Mishima M. Isolation of drug-resistant pathogens does not always require use of broad-spectrum antibiotics in pneumonia. Am J Respir Crit Care Med 189: 756-757, 2014.","DOI":"10.1164\/rccm.201312-2162LE"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8867-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:14:16Z","timestamp":1719508456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8867-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8867-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}